JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
SBDS
5101
DELISTED
Solo Brands Inc
SBDS
| $121K | ﹤0.01% |
421
+110
| +35% | +$21.2K |
2021 Q4
5 quarters
|
|
|
BLCN
5102
DELISTED
Siren ETF Trust Siren NexGen Economy ETF
BLCN
| $121K | ﹤0.01% |
5,622
+3,619
| +181% | +$78.6K |
2022 Q3
2 quarters
|
|
5103
BARK
BARK
$73.2M
| $120K | ﹤0.01% |
4,152
+754
| +22% | +$23.9K |
2021 Q4
5 quarters
|
|
5104
Weave Communications
WEAV
$592M
| $120K | ﹤0.01% |
24,192
+6,501
| +37% | +$32.7K |
2021 Q4
5 quarters
|
|
|
TBCH
5105
Turtle Beach Corp
TBCH
$248M
| $120K | ﹤0.01% |
11,964
+3,097
| +35% | +$26.3K |
2020 Q2
11 quarters
|
|
5106
JPMorgan Diversified Return International Equity ETF
JPIN
$375M
| $119K | ﹤0.01% |
2,286
+1,052
| +85% | +$54.3K |
2015 Q1
32 quarters
|
|
5107
Organogenesis Holdings
ORGO
$166M
| $119K | ﹤0.01% |
55,903
+15,122
| +37% | +$37.4K |
2019 Q1
16 quarters
|
|
|
OKUR
5108
OnKure Therapeutics
OKUR
$107M
| $118K | ﹤0.01% |
1,978
+31
| +2% | +$1.12K |
2022 Q3
2 quarters
|
|
5109
Dimensional Global Sustainability Fixed Income ETF
DFSB
$744M
| $118K | ﹤0.01% |
+2,269
| New | +$117K |
2023 Q1
0 quarters
|
|
|
AZUL
5110
PUT
DELISTED
Azul
AZUL
| $117K | ﹤0.01% |
+16,300
| New | +$102K |
2023 Q1
0 quarters
|
|
5111
InnovAge Holding
INNV
$1.23B
| $117K | ﹤0.01% |
14,653
+3,826
| +35% | +$27.7K |
2021 Q1
8 quarters
|
|
5112
Applied Digital
APLD
$7.39B
| $116K | ﹤0.01% |
51,752
+13,666
| +36% | +$34.1K |
2022 Q2
3 quarters
|
|
|
ASGI
5113
abrdn Global Infrastructure Income Fund
ASGI
$816M
| $116K | ﹤0.01% |
+6,448
| New | +$115K |
2023 Q1
0 quarters
|
|
5114
Savara
SVRA
$982M
| $116K | ﹤0.01% |
59,127
+34,394
| +139% | +$77.5K |
2018 Q1
20 quarters
|
|
|
THRX
5115
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $116K | ﹤0.01% |
13,037
+3,398
| +35% | +$33.4K |
2021 Q4
5 quarters
|
|
5116
Invesco FTSE RAFI Emerging Markets ETF
PXH
$2.09B
| $115K | ﹤0.01% |
6,277
+4,506
| +254% | +$83.3K |
2022 Q4
1 quarter
|
|
5117
BlackRock Health Sciences Trust
BME
$554M
| $115K | ﹤0.01% |
+2,744
| New | +$115K |
2023 Q1
0 quarters
|
|
5118
Lands' End
LE
$314M
| $115K | ﹤0.01% |
11,767
-3,040
| -21% | -$25.5K |
2015 Q4
29 quarters
|
|
|
TEAD
5119
Teads Holding Co
TEAD
$55.5M
| $115K | ﹤0.01% |
28,001
+7,373
| +36% | +$33.4K |
2021 Q3
6 quarters
|
|
|
GSP
5120
DELISTED
Barclays Bank PLC iPath Exchange Traded Notes due 2036 Linked to GSCI Total Return Index
GSP
| $115K | ﹤0.01% |
+5,650
| New | +$117K |
2023 Q1
0 quarters
|
|
5121
VictoryShares US EQ Income Enhanced Volatility Wtd ETF
CDC
$695M
| $114K | ﹤0.01% |
1,888
+56
| +3% | +$3.5K |
2022 Q2
3 quarters
|
|
5122
Bioventus
BVS
$923M
| $114K | ﹤0.01% |
106,258
-235,442
| -69% | -$450K |
2021 Q1
8 quarters
|
|
5123
HF Foods Group
HFFG
$89M
| $114K | ﹤0.01% |
29,050
+7,917
| +37% | +$33K |
2018 Q4
17 quarters
|
|
5124
VanEck Steel ETF
SLX
$162M
| $114K | ﹤0.01% |
1,776
-232
| -12% | -$15K |
2020 Q4
9 quarters
|
|
5125
FT Vest US Equity Buffer ETF August
FAUG
$1.43B
| $112K | ﹤0.01% |
3,080
| – | – |
2022 Q4
1 quarter
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.